HypnoPain Relief for OA
Active, not recruitingNot applicableNCT07850271
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to learn whether HypnoPain Relief (HPR), a brief clinical hypnosis intervention, can help reduce pain and improve quality of life in adults with osteoarthritis. The main questions it aims to answer are: Does HypnoPain Relief reduce pain intensity in adults with osteoarthritis? Does HypnoPain Relief improve osteoarthritis related functioning and quality of life? Researchers will compare participants receiving the HypnoPain Relief intervention with participants receiving a neutral visual exposure condition to see whether the clinical hypnosis intervention improves pain and quality of life outcomes. Participants will: Complete questionnaires about pain, physical functioning, quality of life, emotional symptoms, and psychological well being before and after the intervention and during follow up assessments. Receive either two individual sessions of HypnoPain Relief or two sessions of neutral visual exposure. Complete follow up assessments after the intervention to evaluate changes over time. Participate in physiological measurements during intervention sessions, including brain activity, heart rate variability, skin response, and body temperature measurements.
Study details
- Official title
- Clinical Hypnosis for Pain and Quality of Life in Adults With Osteoarthritis: A Randomized Controlled Trial
- Conditions
- Osteoarthritis (OA)
- Interventions
- Behavioral: HypnoPain Relief (HPR)
- Other: Neutral Visual Exposure Waitlist Control
- Sponsor
- Gadjah Mada University
- Start date
- 2026-05-01
- Primary completion
- 2026-08-30
- Sex
- All
- Age range
- from 30 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Indonesia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 18 to 80 years. * Diagnosis of osteoarthritis confirmed through clinical examination or radiological assessment by a medical professional. * Chronic pain associated with osteoarthritis with a minimum duration of three months. * Pain intensity related to osteoarthritis assessed using the Numeric Rating Scale (NRS). * Able to read and understand Indonesian. * Not currently receiving regular psychological therapy. * Willing and able to participate in all study procedures. * Provide written informed consent before participation. Exclusion Criteria: * Diagnosis of severe psychiatric disorders, including schizophrenia, bipolar disorder, or major depressive disorder with current suicide risk. * Diagnosis of neurological disorders associated with seizure risk, such as epilepsy. * Current regular use of medications with significant central sedative effects, including benzodiazepines, opioid analgesics at sedating doses, or sedating antihistamines. * Current participation in hypnosis or other similar nonpharmacological psychological interventions during the study period. * Hearing impairment or communication difficulties that prevent understanding of study procedures or completing questionnaires. * Serious concurrent medical conditions that may interfere with participation, such as advanced cancer or severe cardiovascular disease. * Inability or unwillingness to complete the intervention sessions and follow up assessments.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07850271